Answer
The selected Respimat product is licensed as add-on treatment for qualifying severe asthma from age 6 years. Safety and efficacy below that age are not established.
Sources for this answer
- Spiriva Respimat 2.5 microgram, inhalation solution — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.